Introduction
The storage of urine within the urinary bladder relies on the contraction of internal and external sphincter muscles located in the neck of the urinary bladder in consort with relaxation of the detrusor muscle. Conversely, urinary bladder voiding is mediated by contraction of the detrusor muscle and relaxation of the sphincter muscles (Thompson, 2004) . Neuronal control of detrusor muscle function is exerted by parasympathetic cholinergic neurons; these neurons are known to store and release both acetylcholine (ACh) and ATP together as co-transmitters from synaptic vesicles (Dowdall et al., 1974; Silinsky and Hubbard, 1973; Whittaker et al., 1972; Unsworth and Johnson, 1990; Silinsky, 1975) . In most mammalian species parasympathetic neurotransmission to the detrusor smooth muscle consists of both a purinergic P2X 1 receptor component mediated by ATP (Vial and Evans, 2000) and a muscarinic receptor component mediated by ACh (Kennedy, 2001 ).
The relative contributions of muscarinic and purinergic components of neurotransmission in detrusor muscle are both species and age dependent. In the mouse, neurotransmission to the urinary bladder detrusor muscle consists of almost equal muscarinic and purinergic components. In contrast, in healthy young adult humans, it is generally believed that neurotransmission in the detrusor muscle is mediated primarily by the muscarinic portion of transmission. However, the purinergic portion of transmission increases both with age and disease, for example in patients suffering from detrusor over-activity (Sjörgen et al., 1982; Kennedy, 2001; Yoshida et al., 2001 ).
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5 Recently, injection of botulinum toxin A (Botox) into the detrusor muscle has been found to be an effective treatment for detrusor over-activity, thus implicating the parasympathetic nerve endings as both a potential cause of overactive bladder and as a target for therapeutic drug discovery. One major side effect of botulinum treatment for overactive bladder is that patients experience bladder voiding impairment (Brubaker et al., 2008; Khan et al., 2009; Shaban and Drake, 2008) . From these observations it appears that understanding the mechanisms for modulation of neurotransmission in bladder detrusor muscle may lead to therapies that could either offer advantages over Botox treatment or alternatively provide mitigation for the voiding impairment induced by Botox treatment through enhancing neurotransmitter release at that portion of nerve terminals unaffected by Botox.
Surprisingly, we know of no previous studies that have exploited the temporal and quantal resolution that might be achieved through the application of electrophysiological techniques to the study of pre-junctional modulation of nerve-evoked neurotransmission purinergic component of evoked transmitter release in murine detrusor muscle.
Phorbol esters are known to cause rapid increases in evoked neurotransmitter release at a wide range of loci -both at central and peripheral nerve endings either through protein kinase C (PKC) -dependent pathways (e.g. Wardell and Cunnane, 1994) or through PKC-independent pathways, which are generally thought to be mediated by Munc13 (Searl and Silinsky, 1998; Betz et al., 1998; see Silinsky and Searl, 2003; Rhee et al., 2002) . Munc13 is a nerve terminal protein containing the C1 phorbol binding domain that through interaction with the SNARE protein syntaxin promotes transmitter release either by increasing the numbers of vesicles available for release (Searl and JPET #194704 6 Silinsky, 2008; Chang et al., 2010) or through effects on the probability of release (Basu et al., 2007) . At a number of synapses both PKC-dependent and PKC-independent pathways have been identified as mechanisms by which phorbol esters promote neurotransmitter release (Lou et al., 2008; Wierda et al., 2007) In addition to the PKC-dependent post-junctional effects of phorbol esters on bladder smooth muscle contraction (e.g. Wang et al., 2012) phorbol esters have been found to exert pre-junctional effects. Thus, phorbol esters were found to increase [ 14 C] ACh overflow in the rat urinary bladder through a M 1 muscarinic receptor dependent PKC pathway, with the effects of phorbol esters inhibited both by PKC inhibitors and also by atropine (Somogyi et al.,1997) . In contrast to these findings, contraction studies in murine detrusor muscle have found application of phorbol esters to selectively increase the purinergic component of neurotransmitter release through a PKC-dependent effect on P/Q type Ca 2+ channels (Liu and Lin-Shiau, 2000) .
The principal aims of this study were three fold, namely 1) to test the feasibility and utility of applying electrophysiological techniques for the measurement of quantal neurotransmitter release in the murine detrusor muscle, 2) to determine the effects of the application of a phorbol ester on the electrophysiological correlate of purinergic transmission in the detrusor muscle and 3) to determine if the acute effects of phorbol dibutyrate on neurotransmitter release in the murine detrusor are mediated through PKC-dependent or PKC-independent mechanisms.
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Results

General Observations
In the absence of any blocking drugs, detrusor muscle preparations contracted both spontaneously and in response to electrical field stimulation of the tissue. Both spontaneous and evoked action potentials could be recorded from detrusor muscle preparations but these events were usually accompanied by contractions and loss of the intracellular muscle impalement. Co-application of the L-type Ca2+ channel blocker, nifedipine (10-15 µM) and the muscarinic antagonist atropine (100 nM) resulted in a rapid abolition of spontaneous contractile activity and a slower abolition of electrically evoked contractions in all preparations. In the combined presence of the ganglionic blocker, hexamethonium, atropine and nifedipine, membrane potentials were quiescent.
Under conditions in which all cholinergic activity and muscle contractions were blocked, intracellular membrane potentials ranged from -32 mV to -58 mV with an average potential of -42.7 ± 1.7 mV (n=41). Electrically-evoked EJPs could be readily recorded in response to field stimulation of the preparation (Fig. 1) as well as sEJPs (see Fig. 1 A) .
The neurogenic origin of these electrically evoked EJPs was tested with the Na + channel blocker tetrodotoxin (TTX). As shown in Fig. 1 A, application of 2 µM TTX resulted in a rapid abolition of the evoked response (n=6) whereas sEJPs persisted in the presence of TTX. The effect of TTX on EJPs was reversible on wash. As shown in 
The effects of phorbol dibutyrate on EJPs recorded from the murine detrusor muscle.
Application of 100 nM phorbol dibutyrate caused a rapid (3-8 minutes onset) augmentation of the electrically evoked EJPs (see Fig. 2A, 3A) . The mean EJP amplitude was 12.1 ± 3.7 mV in control versus 22.4 ± 5.5 mV in PDBu (p=0.018; n=6, Student's paired t-test). In addition, as shown in Fig 3A the amplitudes of sEJPs were unaffected. Specifically the mean sEJP amplitude was 5.7 ± 1.5 mV in control versus 6.7 ± 2.5 mV in PDBu. (Following application of Stevens' correction for non linear summation, EJP amplitudes were 15.5 ± 5.8 mV in control versus 35.3 ± 11.7 mV in PDBu; sEJP amplitudes were 6.11 ± 1.7 mV in control versus 7.47 ± 3.0 in PDBu).
As both PKC-dependent and PKC-independent pathways have been implicated in the effects of phorbol esters on evoked neurotransmitter output, we investigated the abilities (Newton, 1995) . As shown in Figs 3 B and C, these agents had no detectable effect on the evoked response themselves and also had no effect on the increases in evoked response resulting from application of 100 nM phorbol dibutyrate (Applying Stevens' correction for non linear summation, EJP amplitudes were 14.8 ± 6.8 mV in control; 16.6 ± 5.8 mV in GF109 203X; 37.3 ± 13.8 mV in GF109 203X and PDBu. sEJP amplitudes were 5.4 ± 1.5 mV in control; 5.4 ± 1.3 mV in GF109 203X; 5.0
± 1.2 mV in GF109 203X and PDBu). Comparing EJP amplitudes recorded in PDBu
This article has not been copyedited and formatted. The final version may differ from this version. (Sneddon and Burnstock, 1984) . Recordings of electrically evoked EJPs from smooth muscle cells of the rabbit urinary bladder detrusor muscle (using both microelectrode and sucrose gap methods) were first published by Creed et al., (1983) . Later work demonstrated that the atropine-resistant EJPs recorded in the bladders of rabbits, guinea-pigs and pigs were inhibited by desensitization of the ATP receptor with α ,β-meATP (Hoyle and Burnstock, 1985; Fujii, 1988; Brading and Mostwin, 1989; Bramich and Brading, 1996) . In other studies, high concentrations of the purinergic antagonist suramin were found to reduce the amplitude of EJPs recorded by sucrose gap method in rabbit and guinea pig bladder (Creed et al., 1994) . The purinergic component of detrusor muscle neurotransmission was further supported by experiments with whole-cell patch clamped smooth muscle cells isolated from guinea-pig bladder in which concentration jump applications of ATP closely mimicked the time-course of response predicted from recordings of the EJP (Inoue and Brading, 1990) .
Further detailed analysis of intracellularly recorded EJPs recorded in the guinea-pig bladder (Bramich and Brading, 1996; Hashitomi et al., 2000) found that electrically cells at similar distances from the stimulating electrodes, and second that, as the stimulation strength was reduced, the amplitude of EJPs was decreased in two or three discreet steps suggesting that these EJPs are composed of more than one conductance and that the variation in EJP amplitude may be related to the low degree of coupling between smooth muscle cells in and between muscle bundles. More recently, and Young et al. (2008) found that in murine detrusor muscle, sEJPs lead to the production of spontaneous L-type action potentials.
As reported here, in addition to the sEJPs previously recorded from the murine detrusor muscle, electrical field stimulation of the detrusor muscle in the presence of nifedipine, results in the production of EJPs. These electrically-evoked responses (but not the sEJPs) are reversibly blocked by TTX, indicating the dependence of the evoked EJPs on neuronal Na + channels. Also, the evoked EJPs (but not the sEJPs) are abolished by Cd 2+ indicating the dependence of the evoked events on Ca 2+ -channels. Finally both the evoked EJPs and sEJPs are reversibly blocked by the P2X 1 antagonist NF279
indicating the dependency of these events on P2X 1 receptor gated channels.
Initial reports on the effects of phorbol esters on neurotransmitter release often assumed that these effects were mediated through actions on protein kinase C.
However, the discovery of homologous C1 binding domains in proteins other than PKC such as Munc13 led to a reevaluation of the mechanisms underlying the modulatory effects of phorbols on neurotransmitter release at a variety of synapses (see e.g. Searl This suggests that in the detrusor muscle, enhancement of the purinergic component of neurotransmission by phorbol esters is mediated by a non-PKC dependent process i.e.
Munc-13.
Previously, on the basis of radioactively labeled acetylcholine overflow experiments, the enhancement of detrusor neurotransmission by phorbol esters was attributed to the prejunctional actions of PKC (Somogyi et al., 1997) . There are several notable points of difference between our study and those previous reports that might in part account for the difference. Firstly, the effects previously reported pertained to the cholinergic component of neurotransmission which may be under different pre-junctional control than the purinergic component of transmission in detrusor muscle (e.g. Waterman, 1996 but see Lawrence et al., 2010) . In addition, the PKC dependent effect found previously was mediated through an action on L-type Ca 2+ channels. One shortcoming of our approach is the necessary presence of the L-type Ca 2+ channel blocker nifedipine This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on April 30, 2012 as DOI: 10.1124 at ASPET Journals on October 15, 2017 jpet.aspetjournals.org Downloaded from throughout which may mask any prejunctional effect that is exerted through enhancement of L-type Ca 2+ channel function. In addition, the previous report employed both lower concentrations of phorbol ester applied over a much longer time-course than we were regularly able to achieve with electrophysiological techniques. Nevertheless, despite these limitations, our results demonstrate a clear pre-junctional enhancement of electrically evoked neuromuscular transmission by a phorbol ester that is mediated through a PKC-independent pathway.
In conclusion, application of electrophysiological recording techniques to the detrusor muscle of the mouse allows the study of neuromodulation with a degree of resolution not easily attainable with other techniques. In addition, application of the phorbol ester
PDBu results in a PKC-independent increase in neurotransmitter release as determined by the amplitudes of electrically evoked responses. It is likely that the effects of PDBu are mediated through the activation of Munc13 a pre-synaptic protein which contains a phorbol ester binding domain and is thought to enhance release through the promotion of synaptic vesicle priming (Betz et al., 1998; Rhee et al., 2002; Searl and Silinsky, 2003) .
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